Administration, Intravaginal
"Administration, Intravaginal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories.
| Descriptor ID |
D000282
|
| MeSH Number(s) |
E02.319.267.120.500
|
| Concept/Terms |
Administration, Intravaginal- Administration, Intravaginal
- Vaginal Administration
- Administrations, Vaginal
- Vaginal Administrations
- Administration, Vaginal
- Intravaginal Administration
- Administrations, Intravaginal
- Intravaginal Administrations
Instillation, Vaginal- Instillation, Vaginal
- Instillations, Vaginal
- Vaginal Instillation
- Vaginal Instillations
- Vaginal Drug Administration
- Drug Administration, Vaginal
- Administration, Vaginal Drug
- Administrations, Vaginal Drug
- Drug Administrations, Vaginal
- Vaginal Drug Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Intravaginal".
Below are MeSH descriptors whose meaning is more specific than "Administration, Intravaginal".
This graph shows the total number of publications written about "Administration, Intravaginal" by people in this website by year, and whether "Administration, Intravaginal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Administration, Intravaginal" by people in Profiles.
-
Microcrystalline Cellulose and Crospovidone Identified in Placentas With Vaginal Misoprostol Use. Am J Forensic Med Pathol. 2020 Sep; 41(3):176-181.
-
Neither vaginal nor buccal administration of 800??g misoprostol alters mucosal and systemic immune activation or the cervicovaginal microbiome: a pilot study. Eur J Contracept Reprod Health Care. 2016 Dec; 21(6):436-442.
-
Vaginitis. Am Fam Physician. 2011 Apr 01; 83(7):807-15.
-
Vaginal estrogen supplementation during Depo-Provera initiation: a randomized controlled trial. Contraception. 2010 Sep; 82(3):250-5.
-
Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol. 2006 May; 194(5):1283-9.
-
A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus. Infect Dis Obstet Gynecol. 1999; 7(4):186-9.
-
Bacterial vaginosis: efficacy and safety of intravaginal metronidazole treatment. Am J Obstet Gynecol. 1994 Mar; 170(3):759-64.
-
Placebo-controlled trial of intravaginal clindamycin 2% cream for the treatment of bacterial vaginosis. Ann Pharmacother. 1993 Nov; 27(11):1343-5.